. The airline is expecting capacity to decrease between 45% and 55% for June, with operating revenue down 80% to 85%. For May, Southwest now forecasts an 85% to 90% decline in revenue, versus prior estimates of a 90% to 95% decline. "The Company's month-to-date net positive bookings represent a reversal in the net negative booking trends experienced during the majority of March and April 2020, where trip cancellations outpaced new passenger bookings," the filing said.
on Monday following news that Moderna's coronavirus vaccine candidate was showing positive results in early trials. —rose 1% in premarket trading, bouncing back from earlier losses, after reporting results for its fiscal first quarter. The company reported an adjusted loss of $3.20 cents per share and $2.16 billion in revenue, both missing Wall Street estimates, as net sales dropped by more than 40%.
Love it. Let's short everything.
Guidance isn't needed, anyhow.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stock market live updates: Futures flat after big Monday rally, Home Depot falls, Walmart risesA conversation about the latest market-moving news, including earnings from Walmart and Home Depot.
Source: CNBC - 🏆 12. / 72 Read more »
Stock market news today: Dow and S&P 500 updates - CNNOffice Depot stock surged today after announcing Friday it was closing some stores and laying off 13,000 employees, about one-third of its workforce Sad correlation? i thought they been closed up shop. still unfortunate to read. I usually only see 3 employees in my local store, so I'm assuming my store will be self service.
Source: cnnbrk - 🏆 393. / 55 Read more »
Dow futures retreat as stock-market investors await testimony from Powell, MnuchinU.S. stock-index futures indicated a lackluster start of trade on Tuesday, following the best day for the S&P 500 and the Dow since early April. Wall Street will be watching for congressional testimony from Federal Reserve boss Jerome Powell and Treasury Secretary Steven Mnuchin. mr_jettlife Markets will be up at the open! It’s all good as long as they keep those printers running.
Source: MarketWatch - 🏆 3. / 97 Read more »
Stock market news today: Dow and S&P 500 updates - CNNUS stock futures are heading south after the Dow surged more than 900 points Monday. Follow live updates: Not again 🤦🏽♂️🤦🏽♂️ It looks like it’s positive actually... They’re most literally headed north as of this post.
Source: cnnbrk - 🏆 393. / 55 Read more »
5 things to know before the stock market opens MondayDow futures extend their gains and point to an over 600-point gain at Monday's open on positive coronavirus vaccine results.
Source: CNBC - 🏆 12. / 72 Read more »
Moderna's stock soars on positive early-stage data for its coronavirus vaccine candidateShares of Moderna Inc. jumped 25.1% in premarket trading on Monday after the biotechnology company announced positive results from a Phase 1 clinical trial for its experimental mRNA coronavirus vaccine. The trial was done in partnership with the National Institute of Allergy and Infectious Diseases. Within 43 days and after two doses, the participants taking one of two dosing levels of the vaccine candidate reported the same or higher level of antibodies as in blood samples gathered by patients who have recovered from COVID-19, the company said. There were four adverse events during the trial, including one participant who reported a severe skin reaction where the investigational vaccine was administered. "These interim Phase 1 data, while early, demonstrate that vaccination with mRNA-1273 elicits an immune response of the magnitude caused by natural infection starting with a dose as low as 25" micrograms, Moderna chief medical officer Dr. Tal Zaks said in a news release. The next step is a Phase 2 trial, which has been approved to move forward by the Food and Drug Administration. It will focus on two dosing levels (50 microgram and 100 microgram). The early-stage trial had a third dosing level, 250 micrograms. Moderna's vaccine candidate is widely viewed as a frontrunner in the effort to develop the first vaccine for the virus. The preclinical company said earlier this month that the Phase 2 trial will begin "shortly," and on Monday it said it expects a Phase 3 trial to begin in July, if the vaccine is successful in the mid-stage trial. Moderna's stock has soared 240.9% year-to-date. The S&P 500 , in comparison, is down 11.3%. Classic PR stunt... I wonder how many of these pharma companies will mislead us.
Source: MarketWatch - 🏆 3. / 97 Read more »